182 related articles for article (PubMed ID: 29945926)
1. Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma.
Liu L; Sun X; Xie Y; Zhuang Y; Yao R; Xu K
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29945926
[TBL] [Abstract][Full Text] [Related]
2. [Effects of HDAC Inhibitor Scriptaid on IM9 Cell Line and Its Mechanism].
Liu LL; Sun XY; Xie Y; Han DY; Yao RS; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1116-1121. PubMed ID: 30111417
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
Sharma V; Koul N; Joseph C; Dixit D; Ghosh S; Sen E
J Cell Mol Med; 2010 Aug; 14(8):2151-61. PubMed ID: 19583803
[TBL] [Abstract][Full Text] [Related]
4. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
5. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects.
Janaki Ramaiah M; Naushad SM; Lavanya A; Srinivas C; Anjana Devi T; Sampathkumar S; Dharan DB; Bhadra MP
Gene; 2017 Sep; 627():379-386. PubMed ID: 28668345
[TBL] [Abstract][Full Text] [Related]
6. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells.
Li F; Wang T; Wang Z; Chen X; Liu R
Mol Med Rep; 2017 Nov; 16(5):6094-6101. PubMed ID: 28849080
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.
Lee EJ; Lee BB; Kim SJ; Park YD; Park J; Kim DH
Int J Oncol; 2008 Oct; 33(4):767-76. PubMed ID: 18813790
[TBL] [Abstract][Full Text] [Related]
9. Scriptaid effects on breast cancer cell lines.
Giacinti L; Giacinti C; Gabellini C; Rizzuto E; Lopez M; Giordano A
J Cell Physiol; 2012 Oct; 227(10):3426-33. PubMed ID: 22213035
[TBL] [Abstract][Full Text] [Related]
10. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition.
Zhang M; Pan Y; Dorfman RG; Chen Z; Liu F; Zhou Q; Huang S; Zhang J; Yang D; Liu J
Oncotarget; 2016 Apr; 7(16):22285-94. PubMed ID: 26993777
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21
Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J
Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
[TBL] [Abstract][Full Text] [Related]
13. Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21.
Yao R; Han D; Sun X; Xie Y; Wu Q; Fu C; Yao Y; Li H; Li Z; Xu K
Exp Hematol; 2018 Apr; 60():63-72. PubMed ID: 29305109
[TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.
Abaza MS; Bahman AM; Al-Attiyah RJ; Kollamparambil AM
Tumour Biol; 2012 Dec; 33(6):1951-72. PubMed ID: 23011889
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells.
Janyst K; Janyst M; Siernicka M; Lasek W
Oncol Rep; 2018 Apr; 39(4):1999-2005. PubMed ID: 29436692
[TBL] [Abstract][Full Text] [Related]
16. Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.
Sun N; Uda Y; Azab E; Kochen A; Santos RNCE; Shi C; Kobayashi T; Wein MN; Divieti Pajevic P
J Biol Chem; 2019 Jun; 294(25):9722-9733. PubMed ID: 31068415
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors.
Goehringer N; Biersack B; Peng Y; Schobert R; Herling M; Ma A; Nitzsche B; Höpfner M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445133
[TBL] [Abstract][Full Text] [Related]
18. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway.
He C; Wu T; Hao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):3093-3099. PubMed ID: 30146257
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]